封面
市場調查報告書
商品編碼
1726404

全球微生物附著量測試市場:市場規模、佔有率、趨勢分析(按產品、測試類型、應用、最終用途和地區)、細分市場預測(2025-2030 年)

Bioburden Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test Type, By Application (Raw Material Testing), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

微生物附著量測試市場的成長和趨勢:

根據Grand View Research, Inc.的最新報告,全球微生物附著量測試市場規模預計到2030年將達到32.2億美元,預計2025年至2030年期間的複合年成長率為14.5%。

由於人們對產品安全的擔憂日益加劇,預計未來幾年市場將呈現上升趨勢。為此,政府正在採取各種措施來推廣微生物安全檢測工具。

許多組織發表了大量出版物來提高人們對微生物安全測試的認知,並拓寬了微生物附著量測試的未來發展前景。例如,美國衛生與公眾服務部和疾病管制中心出版了《微生物和生物醫學實驗室的生物安全》(BMBL),其中包含與實驗室生物安全和風險評估、淨化和滅菌、生物毒素和實驗室生物安全水平相關的資訊。

製藥、生物技術、醫療設備以及食品飲料行業的成長推動了微生物附著量測試市場的快速成長。此外,知名公司增加研發投入預計將鼓勵最終用戶採用高效的微生物附著量測試工具來應對因微生物污染造成的損失。此外,臨床前試驗中對基本藥物安全數據的需求預計將推動對微生物附著量測試工具的需求。

微生物附著量測試市場:分析概述

  • 耗材在微生物附著量測試市場佔據主導地位,2024 年佔據最高收益佔有率,為 66.4%。此部分進一步分為培養基、試劑和套件。
  • 需氣菌計數檢測將引領微生物附著量檢測市場,到 2024 年將佔據最大的收益佔有率,達到 36.6%。
  • 原料測試部分將主導微生物附著量測試市場,2024 年的最大收益佔有率為 30.4%。
  • 製藥和生物技術公司將主導微生物附著量測試市場,佔據 2024 年最大的收益佔有率。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章微生物附著量測試市場:促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析:波特五力分析
    • PESTEL分析

第4章微生物附著量測試市場:按產品分類的業務分析

  • 各產品市場佔有率(2024 年及 2030 年)
  • 產品儀表板
  • 市場規模預測及產品趨勢分析(2018-2030)
  • 耗材
  • 裝置

第5章微生物附著量測試市場:按測試類型進行的業務分析

  • 按測試類型分類的市場佔有率(2024 年和 2030 年)
  • 考試類型儀表板
  • 按測試類型分類的市場規模預測和趨勢分析(2018-2030)
  • 需氣菌計數檢測
  • 厭氧菌計數檢測
  • 真菌/黴菌計數測試
  • 孢子計數測試

第6章微生物附著量測試市場:按應用進行的業務分析

  • 按應用分類的市場佔有率(2024 年和 2030 年)
  • 特定於應用程式的儀表板
  • 按應用分類的市場規模預測和趨勢分析(2018-2030)
  • 原料檢測
  • 醫療設備測試
  • 進程內的材料測試
  • 滅菌驗證測試
  • 設備清洗驗證

第7章微生物附著量測試市場:依最終用途的業務分析

  • 按最終用途分類的市場佔有率(2024 年和 2030 年)
  • 最終用途儀表板
  • 按最終用途分類的市場規模預測和趨勢分析(2018-2030 年)
  • 製藥和生物技術公司
  • 製藥和生物技術市場(2018-2030)
  • 醫療設備製造商
  • 契約製造組織
  • 食品飲料及農產品製造商
  • 微生物實驗室

第8章微生物附著量測試市場:按地區估計和趨勢分析

  • 各地區市場佔有率(2024 年及 2030 年)
  • 區域市場儀表板
  • 市場規模預測及趨勢分析(2018-2030年)
  • 北美洲
    • 按國家/地區(2018-2030 年)
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區(2018-2030 年)
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 按國家/地區(2018-2030 年)
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 按國家/地區(2018-2030 年)
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區(2018-2030 年)
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 市場參與企業概況
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Charles River Laboratories
    • Merck KGaA
    • SGS SA
    • WuXi AppTec
    • BD
    • North American Science Associates Inc.
    • Nelson Laboratories, LLC
    • Thermo Fisher Scientific Inc.
    • BIOMERIEUX
    • Pacific Biolabs
Product Code: GVR-3-68038-774-2

Bioburden Testing Market Growth & Trends:

The global bioburden testing market size is estimated to reach USD 3.22 billion by 2030, registering to grow at a CAGR of 14.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The market is expected to showcase upward trend in the forthcoming years owing to growing concerns about product safety. This has led to various government initiatives to promote microbiological safety testing tools.

A number of publications released by organizations to promote awareness regarding microbiological safety testing is broadening the future growth prospects of bioburden testing. For instance, the U.S. Department of Health and Human Services and Centers for Disease Control published Biosafety in Microbiological and Biomedical Laboratories (BMBL), which includes information pertaining to laboratory biosecurity and risk assessment, decontamination and sterilization, and biological toxins and biosafety levels in laboratories.

Growth of pharmaceutical, biotechnology, medical device, and food and beverage industries have contributed to the high growth of the bioburden testing market. In addition, increase in R&D investments by prominent companies is expected to encourage end users to adopt highly efficient bioburden testing tools to counter possible losses due to microbial contamination. Moreover, requirement for basic drug safety data requirements for preclinical studies is expected to fuel the demand for bioburden testing tools.

Bioburden Testing Market Report Highlights:

  • Consumables dominated the bioburden testing market, accounting for the highest revenue share of 66.4% in 2024. The segment is further divided into culture media, reagents, and kits.
  • Aerobic count testing led the bioburden testing market, accounting for the largest revenue share of 36.6% in 2024.
  • The raw material testing sector dominated the bioburden testing market, with the largest revenue share of 30.4% in 2024.
  • Pharmaceutical and biotechnology companies dominated the bioburden testing market with the largest revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Test Type
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Bioburden Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Bioburden Testing Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.2. Culture Media
      • 4.4.2.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.3. Reagents and Kits
      • 4.4.3.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.5.2. Automated Microbial Identification Systems
      • 4.5.2.1. Automated Microbial Identification Systems Market, 2018 - 2030 (USD Million)
    • 4.5.3. PCR Instruments
      • 4.5.3.1. PCR Instruments Market, 2018 - 2030 (USD Million)

Chapter 5. Bioburden Testing Market: Test Type Business Analysis

  • 5.1. Test Type Market Share, 2024 & 2030
  • 5.2. Test Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
  • 5.4. Aerobic Count Testing
    • 5.4.1. Aerobic Count Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Anaerobic Count Testing
    • 5.5.1. Anaerobic Count Testing Market, 2018 - 2030 (USD Million)
  • 5.6. Fungi/Mold Count Testing
    • 5.6.1. Fungi/Mold Count Testing Market, 2018 - 2030 (USD Million)
  • 5.7. Spore Count Testing
    • 5.7.1. Spore Count Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Bioburden Testing Market: Application Business Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Raw Material Testing
    • 6.4.1. Raw Material Testing Market, 2018 - 2030 (USD Million)
  • 6.5. Medical Device Testing
    • 6.5.1. Medical Device Testing Market, 2018 - 2030 (USD Million)
  • 6.6. In-Process Material Testing
    • 6.6.1. In-Process Material Testing Market, 2018 - 2030 (USD Million)
  • 6.7. Sterilization Validation Testing
    • 6.7.1. Sterilization Validation Testing Market, 2018 - 2030 (USD Million)
  • 6.8. Equipment Cleaning Validation
    • 6.8.1. Equipment Cleaning Validation Market, 2018 - 2030 (USD Million)

Chapter 7. Bioburden Testing Market: End Use Business Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
  • 7.5. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.6. Medical Device Manufacturers
    • 7.6.1. Medical Device Manufacturers Market, 2018 - 2030 (USD Million)
  • 7.7. Contract Manufacturing Organizations
    • 7.7.1. Contract Manufacturing Organizations Market, 2018 - 2030 (USD Million)
  • 7.8. Manufacturers of Food & Beverage and Agricultural Products
    • 7.8.1. Manufacturers of Food & Beverage and Agricultural Products Market, 2018 - 2030 (USD Million)
  • 7.9. Microbial Testing Laboratories
    • 7.9.1. Microbial Testing Laboratories Market, 2018 - 2030 (USD Million)

Chapter 8. Bioburden Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Denmark Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Sweden Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Norway Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. Australia Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. South Korea Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Charles River Laboratories
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Merck KGaA
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. SGS SA
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. WuXi AppTec
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. BD
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. North American Science Associates Inc.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Nelson Laboratories, LLC
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Thermo Fisher Scientific Inc.
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. BIOMERIEUX
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Pacific Biolabs
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global bioburden testing market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 6. Global bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 7. Global bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8. North America bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 9. North America bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 10. North America bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 11. North America bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 12. North America bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 13. U.S. bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 14. U.S. bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 15. U.S. bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 16. U.S. bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Canada bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 18. Canada bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 19. Canada bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 20. Canada bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21. Mexico bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 22. Mexico bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 23. Mexico bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 24. Mexico bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Europe bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 26. Europe bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 27. Europe bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 28. Europe bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 29. Europe bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30. UK bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 31. UK bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 32. UK bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 33. UK bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Germany bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 35. Germany bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 36. Germany bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 37. Germany bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38. France bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 39. France bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 40. France bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 41. France bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Italy bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 43. Italy bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 44. Italy bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 45. Italy bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Spain bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 47. Spain bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 48. Spain bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 49. Spain bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50. Denmark bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 51. Denmark bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 52. Denmark bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 53. Denmark bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Sweden bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 55. Sweden bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 56. Sweden bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 57. Sweden bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 58. Norway bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 59. Norway bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 60. Norway bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 61. Norway bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 67. Japan bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 68. Japan bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 69. Japan bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 70. Japan bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 71. China bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 72. China bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 73. China bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 74. China bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75. India bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 76. India bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 77. India bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 78. India bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79. Australia bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 80. Australia bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 81. Australia bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 82. Australia bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 83. South Korea bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 84. South Korea bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 85. South Korea bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 86. South Korea bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Thailand bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 88. Thailand bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 89. Thailand bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 90. Thailand bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 91. Latin America bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 92. Latin America bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 93. Latin America bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 94. Latin America bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 95. Latin America bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 96. Brazil bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 97. Brazil bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 98. Brazil bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 99. Brazil bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 100. Argentina bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 101. Argentina bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 102. Argentina bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 103. Argentina bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 104. MEA bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 105. MEA bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 106. MEA bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 107. MEA bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 108. MEA bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 109. South Africa bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 110. South Africa bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 111. South Africa bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 112. South Africa bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 117. UAE bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 118. UAE bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 119. UAE bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 120. UAE bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 122. Kuwait bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 123. Kuwait bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 124. Kuwait bioburden testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Bioburden testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product outlook (USD Million)
  • Fig. 10 Test type outlook (USD Million)
  • Fig. 11 Application outlook (USD Million)
  • Fig. 12 End use outlook (USD Million)
  • Fig. 13 Competitive landscape
  • Fig. 14 Bioburden testing market dynamics
  • Fig. 15 Bioburden testing market: Porter's five forces analysis
  • Fig. 16 Bioburden testing market: Pestle analysis
  • Fig. 17 Bioburden testing market: Product segment dashboard
  • Fig. 18 Bioburden testing market: Product market share analysis, 2024 & 2030
  • Fig. 19 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 20 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 21 Bioburden testing market: Test type segment dashboard
  • Fig. 22 Bioburden testing market: Test type market share analysis, 2024 & 2030
  • Fig. 23 Aerobic count testing market, 2018 - 2030 (USD Million)
  • Fig. 24 Anaerobic count testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Fungi/Mold count testing market, 2018 - 2030 (USD Million)
  • Fig. 26 Spore count testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Bioburden testing market: Application segment dashboard
  • Fig. 28 Bioburden testing market: Application market share analysis, 2024 & 2030
  • Fig. 29 Raw material testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Medical device testing market, 2018 - 2030 (USD Million)
  • Fig. 31 In-process material testing market, 2018 - 2030 (USD Million)
  • Fig. 32 Sterilization validation testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Equipment cleaning validation market, 2018 - 2030 (USD Million)
  • Fig. 34 Bioburden testing market: End use segment dashboard
  • Fig. 35 Bioburden testing market: End use market share analysis, 2024 & 2030
  • Fig. 36 Pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 37 Medical device manufacturers market, 2018 - 2030 (USD Million)
  • Fig. 38 Contract manufacturing organizations market, 2018 - 2030 (USD Million)
  • Fig. 39 Manufacturers of food & beverage and agricultural products market, 2018 - 2030 (USD Million)
  • Fig. 40 Microbial testing laboratories market, 2018 - 2030 (USD Million)
  • Fig. 41 Bioburden testing market revenue, by region
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. country dynamics
  • Fig. 46 U.S. bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada country dynamics
  • Fig. 48 Canada bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico country dynamics
  • Fig. 50 Mexico bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 51 Europe bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 52 UK country dynamics
  • Fig. 53 UK bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 54 Germany country dynamics
  • Fig. 55 Germany bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 56 France country dynamics
  • Fig. 57 France bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy country dynamics
  • Fig. 59 Italy bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 60 Spain country dynamics
  • Fig. 61 Spain bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden country dynamics
  • Fig. 65 Sweden bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 69 Japan country dynamics
  • Fig. 70 Japan bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 71 China country dynamics
  • Fig. 72 China bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 73 India country dynamics
  • Fig. 74 India bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Australia country dynamics
  • Fig. 76 Australia bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea country dynamics
  • Fig. 78 South Korea bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 79 Thailand country dynamics
  • Fig. 80 Thailand bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 82 Brazil country dynamics
  • Fig. 83 Brazil bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina country dynamics
  • Fig. 85 Argentina bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 86 MEA bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa country dynamics
  • Fig. 88 South Africa bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia country dynamics
  • Fig. 90 Saudi Arabia bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 91 UAE country dynamics
  • Fig. 92 UAE bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 93 Kuwait country dynamics
  • Fig. 94 Kuwait bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 95 Company categorization
  • Fig. 96 Company market position analysis
  • Fig. 97 Strategic framework